Press Release

TGaS Advisors Promotes Carro to Principal, Appoints Kain and Sharp to Lead Marketing Sciences Operations and Compliance Solutions

East Norriton, Penn., January 19, 2010 – TGaS^® Advisors , the leader in benchmarking and advisory services for pharmaceutical commercial operations, announced that John Carro was promoted to Principal. The firm also hired John C. Kain as Vice President, Management Advisor, Marketing Sciences, and Kevin C. Sharp, Director, Management Advisor, Commercial Compliance Solutions.

Carro, who came to TGaS Advisors in 2008, was previously Vice President, Management Advisor, Sales Operations Practice. Stephen E. Gerard, TGaS Advisors Managing Partner, said, “John’s senior-level experience in a broad range of pharmaceutical companies and positions gives him a rare cross-functional perspective in virtually every aspect of commercial operations. He is an invaluable asset to clients and to us.”

Kain leads the firm’s Marketing Sciences solutions, including strategy, management and client advisory services across such key functions as primary and secondary research, marketing analytics, forecasting, competitive intelligence and business development. Kain has led pharmaceutical market research and analytics teams for nearly two decades, working with such firms as ImpactRx, NDC Health Information Services (now Wolters Kluwer Health) and others. During his career, Kain has worked with the Marketing Sciences functions of the majority of the large and mid-tier biopharmaceutical companies. He is a graduate of Drexel University.

Sharp, Director, Management Advisor, is responsible for the firm’s Commercial Compliance Solutions, including Commercial Compliance Operations and PDMA. One of TGaS Advisors’ newest and fastest growing solutions, Commercial Compliance covers such areas as anti-kickback, state reporting, false claims, OIG and PhRMA codes in addition to PDMA. Sharp is currently enrolling companies in a Commercial Compliance benchmark designed to help them identify areas of risk, optimize compliance requirements and understand the most current thinking with respect to meeting regulatory requirements.

Sharp, who helped develop the Commercial Compliance Solution as a consultant, is experienced in sales managerial operations, business development and client services. He supported global data management, sample administration and sales force automation at Wyeth Pharmaceuticals and has held positions at Publicis Selling Solutions, HighPoint Solutions and Archi-Tech Systems. Sharp, who studied Business Administration at Bloomsburg University and Marketing Leadership at Wharton Business School, also served in the U.S. Army.

Gerard commented: “We are fortunate to have three such experienced practitioners on board at a time when business strategy, compliance and market research are of such critical importance to the pharmaceutical industry. As counselors to the top companies, we know these areas are of primary interest to companies in this uncertain environment.”

About TGaS^® Advisors

TGaS Advisors, ranked in the top 50 among U.S. Business Products & Services companies by the Inc. 500, is the leader in benchmarking and advisory services to the pharmaceutical and biopharmaceutical industry. The TGaS Advisors roster includes the top 10 and the majority of the top 50 pharmaceutical companies with operations in the U.S. market. The firm’s benchmarking and advisory services suite of solutions, PharmaStance^®, provides clients with a way to measure where they stand with respect to their organizations and answers the question, “How do other pharmaceutical companies do ‘it’?”^® TGaS Advisors is based in East Norriton, Pennsylvania.

Other Press Releases:

TGaS Advisors Named to Inc. 5000; Among Top 20 in Philadelphia Area

Managed Markets Marketing Leaders Debate Channel Strategy, Healthcare Reform, Career Issues at TGaS Advisors Summit

TGaS Advisors Launches Three New Pharmaceutical Benchmark Options: Best of Benchmark, Efficiency Benchmark and Strategic Priorities Benchmark

New Commercial Models, Healthcare Reform, Cross-Organizational Talent Needs Pose Challenges for Pharma Operations Execs at TGas Advisors’ Leadership Summit

TGaS Advisors Offers Proxy Measures, Best Practices in Digital Marketing Metrics at PMSA Conference

Solving Managed Markets Staffing Dilemma: New Account Manager Sizing Model

Pharma Executives Bullish on Companies, Industry for 2010: TGaS Advisors 2010 Confidence Index

TGaS Advisors’ Mercante Speaks on New Data Sources in the Digital Age, New Competitve Strategies for the Pharmaceutical Industry

“What’s Your DMI?” TGaS Advisors Launches the First and Only One-Number Digital Marketing Measure

TGaS Advisors “Snapshot” of Commercial Operations Shows Concern for Gaps in Execution and Monitoring

2009

2008

2007